These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3459761)

  • 21. Gingival sequestration of nifedipine in nifedipine-induced gingival overgrowth.
    Ellis JS; Seymour RA; Monkman SC; Idle JR
    Lancet; 1992 Jun; 339(8806):1382-3. PubMed ID: 1350808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteins of the periodontium. Biochemical studies on the collagen and noncollagenous proteins of human gingivae.
    Ballard JB; Butler WT
    J Oral Pathol; 1974; 3(4):176-84. PubMed ID: 4219028
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ultrastructural findings in a case of diphenylhydantoin gingival hyperplasia].
    La Torre G; Carrozza G; Calabrò S; Stagno D'Alcontres A; Busà S
    Stomatol Mediterr; 1987; 7(3):307-11. PubMed ID: 3508968
    [No Abstract]   [Full Text] [Related]  

  • 24. Collagenolysis by human gingival fibroblast cell lines.
    Rose GG; Robertson PB
    J Dent Res; 1977 Apr; 56(4):416-24. PubMed ID: 265971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diphenylhydantoin gingival hyperplasia: incidence and etiology.
    Zeitler DL; Zach GA
    J Hosp Dent Pract; 1980; 14(1):41-4. PubMed ID: 6964964
    [No Abstract]   [Full Text] [Related]  

  • 26. Diphenylhydantoin (dilantin) gingival hyperplasia: drug-induced abnormality of connective tissue.
    Hassell TM; Page RC; Narayanan AS; Cooper CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2909-12. PubMed ID: 1066702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diphenylhydantoin gingival hyperplasia: ultrastructural study].
    Aragona F; Franco V; Margiotta V; Cabibi D
    Stomatol Mediterr; 1988; 8(2):85-93. PubMed ID: 3256935
    [No Abstract]   [Full Text] [Related]  

  • 28. [Gingival hyperplasia induced by nifedipine. Effect of nifedipine and EGF on cell proliferation in human gingival fibroblasts].
    Nishikawa S; Ueno A; Ishida H; Nagata T; Hamasaki A; Koda N; Kido J; Wakano Y
    Nihon Shishubyo Gakkai Kaishi; 1986 Mar; 28(1):168-75. PubMed ID: 3487604
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gingival hyperplasia and diphenylhydantoin].
    Barone GP; Arata E; Salmeri S; Patrone M
    Parodontol Stomatol (Nuova); 1984; 23(3 Suppl 3):149-55. PubMed ID: 6443491
    [No Abstract]   [Full Text] [Related]  

  • 30. Lack of relationship between the degree of induced gingival hyperplasia and the concentration of diphenylhydantoin in various tissues of ferrets.
    Steinberg AD; Alvarez J; Jeffay H
    J Dent Res; 1972; 51(2):657-62. PubMed ID: 4501305
    [No Abstract]   [Full Text] [Related]  

  • 31. The major metabolite of phenytoin (Dilantin) induces gingival overgrowth in cats.
    Hassell TM; Page RC
    J Periodontal Res; 1978 May; 13(3):280-2. PubMed ID: 149199
    [No Abstract]   [Full Text] [Related]  

  • 32. [Gingival hyperplasia due to Dihydan. A semi-quantitative and ultrastrctural study].
    Boudat MA; Kerebel B
    J Parodontol; 1985 Oct; 4(4):301-10. PubMed ID: 3869240
    [No Abstract]   [Full Text] [Related]  

  • 33. [Histamine content in various diseases of the gingiva].
    Terner K; Muszbek L; Csaba B
    Stoma (Heidelb); 1969 May; 22(2):100-3. PubMed ID: 5255753
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of inflammation in the pathogenesis of gingival enlargement during the administration of diphenylhydantoin sodium in cats.
    Nuki K; Cooper SH
    J Periodontal Res; 1972; 7(2):102-10. PubMed ID: 4272036
    [No Abstract]   [Full Text] [Related]  

  • 35. Study of diphenylhydantoin gingival hyperplasia among Egyptian children.
    Soliman NA; el-Ashiry GM; el-Gally KA; Attia MA
    Egypt Dent J; 1978 Jan; 24(1):11-22. PubMed ID: 292569
    [No Abstract]   [Full Text] [Related]  

  • 36. [Gingival hyperplasia in epileptic patients treated with diphenylhydantoin. Study by light and electron microscopy].
    Tsutsumi V; Hara Ortíz F; Alvarez Fuertes G
    Rev Invest Salud Publica; 1973; 33(3-4):1-16. PubMed ID: 4791088
    [No Abstract]   [Full Text] [Related]  

  • 37. A clinicopathological review. Diphenylhydantoin gingival hyperplasia: 2. Aetiology, pathogenesis, differential diagnosis and treatment.
    Angelopoulos AP
    Dent J; 1975 May; 41(5):275-7, 283. PubMed ID: 1055114
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental study of tissue culture on the etiology of 5,5-diphenylhydantoin gingival hyperplasia].
    Yoshizumi T
    Shikwa Gakuho; 1971 Jan; 71(1):183-207. PubMed ID: 5278118
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction of phenytoin and inflammation induces gingival overgrowth in rats.
    do Nascimento A; Barreto Rde C; Bozzo L; de Almeida OP
    J Periodontal Res; 1985 Jul; 20(4):386-91. PubMed ID: 2933503
    [No Abstract]   [Full Text] [Related]  

  • 40. Dilantin (diphenylhydantoin): its effects on the gingival tissue.
    Bergmann CL
    Dent Dig; 1967 Feb; 73(2):63-70. PubMed ID: 5225921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.